Back to PollNow

Back to companies

GILEAD SCIENCES, INC.

GILDUSNASDAQPharmaceuticals & Healthcare

GILEAD SCIENCES, INC.

Revenue

$29.4bn

YoY +2.4%

Operating income

$10.0bn

FY2025

Employees

—

Founded

—

Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API